T1 Organism 959 962 men
T2 Condition 157 197 non-castrate metastatic prostate cancers
T3 Organism 1553 1561 patients
T4 Protein 1044 1047 PSA
T5 Protein 574 595 retroperitoneal nodes
T6 Organism 1069 1072 men
T7 Organism 1353 1361 patients
T8 Gene 832 857 prostate-specific antigen
T9 Organism 1092 1100 patients
T10 Disease 1417 1421 M1b 
T11 Protein 859 862 PSA
T12 Biomarker 1639 1651 testosterone
T13 Biomarker 430 438 androgen
T14 Protein 1629 1632 PSA
T15 Organism 780 788 patients
T16 Disease 1417 1428 M1b disease
T17 Biomarker 1107 1115 androgen
T18 Organism 695 698 men
T19 Intervention 615 619 body
T20 Organism 137 140 men
T21 Condition 292 312 oligometastatic M1a 
T22 Organism 283 286 men
T23 Organism 1226 1234 patients
T24 Biomarker 728 736 Androgen
T25 Organism 1494 1497 men
T26 Intervention 636 643 osseous
T27 Biomarker 870 882 testosterone
T28 Disease 343 347 M1b 
R1 Relation Arg1:T13 Arg2:T18
R2 Relation Arg1:T22 Arg2:T13
R3 Relation Arg1:T19 Arg2:T18
R4 Relation Arg1:T26 Arg2:T18
R5 Relation Arg1:T22 Arg2:T19
R6 Relation Arg1:T19 Arg2:T26
